Molecular Therapy - Methods & Clinical Development

Slides:



Advertisements
Similar presentations
Cell & Gene Therapy 2014, Las Vegas, NV October 27–29, 2014
Advertisements

Enhanced delivery of DNA-based vaccines and immunotherapeutics through next-generation electroporation devices Stephanie Ramos, Ph.D. Inovio Pharmaceuticals.
8th International Conference and Exhibition on:
Molecular Therapy - Methods & Clinical Development
Molecular Therapy - Methods & Clinical Development
Generation of new peptide-Fc fusion proteins that mediate antibody-dependent cellular cytotoxicity against different types of cancer cells  Mouldy Sioud,
Successful Use of mRNA-Nucleofection for Overexpression of Interleukin-10 in Murine Monocytes/Macrophages for Anti-inflammatory Therapy in a Murine Model.
Volume 17, Issue 9, Pages (September 2009)
Dynamic Changes in Resident and Infiltrating Epidermal Dendritic Cells in Active and Resolved Psoriasis  Elisa Martini, Maria Wikén, Stanley Cheuk, Irène.
The Tumor Necrosis Factor Superfamily Molecule LIGHT Promotes Keratinocyte Activity and Skin Fibrosis  Rana Herro, Ricardo Da S. Antunes, Amelia R. Aguilera,
Volume 19, Issue 1, Pages (July 2003)
The Humoral Immune Response Is Initiated in Lymph Nodes by B Cells that Acquire Soluble Antigen Directly in the Follicles  Kathryn A. Pape, Drew M. Catron,
Critical Role for Skin-Derived Migratory DCs and Langerhans Cells in TFH and GC Responses after Intradermal Immunization  Clément Levin, Olivia Bonduelle,
Volume 21, Issue 10, Pages (October 2013)
Volume 44, Issue 1, Pages (January 2016)
Gregory D. Rak, Lisa C. Osborne, Mark C. Siracusa, Brian S
by Dior Kingston, Michael A
Volume 40, Issue 2, Pages (February 2014)
Nanoparticle-Based Targeting of Vaccine Compounds to Skin Antigen-Presenting Cells By Hair Follicles and their Transport in Mice  Brice Mahe, Annika Vogt,
Alexandra C. I. Depelsenaire, Stefano C. Meliga, Celia L
Molecular Therapy - Nucleic Acids
Volume 18, Issue 5, Pages (May 2010)
Molecular Therapy - Methods & Clinical Development
Generation of new peptide-Fc fusion proteins that mediate antibody-dependent cellular cytotoxicity against different types of cancer cells  Mouldy Sioud,
Molecular Therapy - Methods & Clinical Development
Volume 18, Issue 10, Pages (October 2010)
Molecular Therapy - Methods & Clinical Development
Loss of EPC-1/PEDF Expression During Skin Aging In Vivo
Sandra Holzmann, BSc, Christoph H
Volume 22, Issue 10, Pages (October 2014)
Volume 23, Issue 6, Pages (December 2005)
Zihua Zeng, Ching-Hsuan Tung, Youli Zu 
Molecular Therapy - Methods & Clinical Development
Molecular Therapy - Nucleic Acids
by Silvia Mele, Stephen Devereux, Andrea G
Volume 25, Issue 6, Pages (June 2017)
Volume 25, Issue 1, Pages (January 2017)
Volume 37, Issue 5, Pages (November 2012)
Volume 21, Issue 10, Pages (October 2013)
Volume 23, Issue 10, Pages (October 2015)
Molecular Therapy - Methods & Clinical Development
CD24a Expression Levels Discriminate Langerhans Cells from Dermal Dendritic Cells in Murine Skin and Lymph Nodes  Susanne Stutte, Bettina Jux, Charlotte.
Codon-Optimized P1A-Encoding DNA Vaccine: Toward a Therapeutic Vaccination against P815 Mastocytoma  Alessandra Lopes, Kevin Vanvarenberg, Véronique Préat,
Volume 23, Issue 7, Pages (July 2015)
Incorporation of the B18R Gene of Vaccinia Virus Into an Oncolytic Herpes Simplex Virus Improves Antitumor Activity  Xinping Fu, Armando Rivera, Lihua.
Molecular Therapy - Nucleic Acids
Volume 21, Issue 1, Pages (January 2013)
Volume 6, Issue 1, Pages (July 2002)
Volume 14, Issue 2, Pages (February 2001)
Efficient Induction of CD8 T-Associated Immune Protection by Vaccination with mRNA Transfected Dendritic Cells  Shohreh Zarei, Jean-François Arrighi,
Exosomes from M1-Polarized Macrophages Potentiate the Cancer Vaccine by Creating a Pro-inflammatory Microenvironment in the Lymph Node  Lifang Cheng,
Modular Three-component Delivery System Facilitates HLA Class I Antigen Presentation and CD8+ T-cell Activation Against Tumors  Benjamin J Umlauf, Chin-Ying.
Computer-assisted Hydrodynamic Gene Delivery
Engagement of CD47 Inhibits the Contact Hypersensitivity Response Via the Suppression of Motility and B7 Expression by Langerhans Cells  Xijun Yu, Atsushi.
A Mouse Model of Vitiligo with Focused Epidermal Depigmentation Requires IFN-γ for Autoreactive CD8+ T-Cell Accumulation in the Skin  John E. Harris,
Sandra Holzmann, BSc, Christoph H
Volume 24, Issue 1, Pages (January 2016)
Volume 19, Issue 3, Pages (March 2011)
Volume 8, Issue 2, Pages (August 2003)
Epicutaneous Application of CpG Oligodeoxynucleotides with Peptide or Protein Antigen Promotes the Generation of CTL  Sandra K. Klimuk, Hossain M. Najar,
Volume 26, Issue 1, Pages (January 2018)
Volume 8, Issue 2, Pages (August 2003)
Volume 25, Issue 4, Pages (April 2017)
Sindbis Viral Vectors Transiently Deliver Tumor-associated Antigens to Lymph Nodes and Elicit Diversified Antitumor CD8+ T-cell Immunity  Tomer Granot,
Y. Albert Pan, Joshua R. Sanes  Journal of Investigative Dermatology 
Genetic Immunization With In Vivo Dendritic Cell-targeting Liposomal DNA Vaccine Carrier Induces Long-lasting Antitumor Immune Response  Arup Garu, Gopikrishna.
MRNA Vaccine with Antigen-Specific Checkpoint Blockade Induces an Enhanced Immune Response against Established Melanoma  Yuhua Wang, Lu Zhang, Zhenghong.
Loss of Transgene following ex vivo Gene Transfer is Associated with a Dominant Th2 Response: Implications for Cutaneous Gene Therapy  Zhenmei Lu, Soosan.
Molecular Therapy - Methods & Clinical Development
Molecular Therapy - Nucleic Acids
Presentation transcript:

Molecular Therapy - Methods & Clinical Development DNA vaccination strategy targets epidermal dendritic cells, initiating their migration and induction of a host immune response  Trevor RF Smith, Katherine Schultheis, William B Kiosses, Dinah H Amante, Janess M Mendoza, John C Stone, Jay R McCoy, Niranjan Y Sardesai, Kate E Broderick  Molecular Therapy - Methods & Clinical Development  Volume 1, (January 2014) DOI: 10.1038/mtm.2014.54 Copyright © 2014 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 1 Accelerated immunity after DNA vaccination targeting the dendritic cell-rich epidermis. (a) Image of guinea pig epidermis highlighting Langerhans cell populations after ATPase staining. Magnification 40×. (b) The kinetics of the generation of humoral immunity was detected by enzyme-linked immunosorbent assay after skin or muscle pH5HA immunization of Hartley guinea pigs. Peripheral blood IgG against the A/Vietnam/2004 H5HA antigen end point titers are plotted (mean + standard error of the mean). *P < 0.05 = end point titer between skin and muscle immunization groups (five guinea pigs per group). ↑ = immunization day. Molecular Therapy - Methods & Clinical Development 2014 1, DOI: (10.1038/mtm.2014.54) Copyright © 2014 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 2 Panoramic image of the dermal tissue after pDNA delivery in the presence of surface electroporation (SEP). Guinea pigs were treated intradermally with 50 µg pRFP and the injection site immediately electroporated with the SEP device. The mapped and stitched multipanel and multisection confocal image reconstruction revealed reporter gene (red fluorescent protein (RFP)) expression in the epidermal layer of guinea pig skin aligned to the site where plasmid injection and electroporation with SEP was performed. Image acquired 6 hours after treatment. Magnification 10×. D, dermis; ED, epidermis; SC, stratum corneum. RFP (red), K10 stain (green), Hoechst (blue). Scale bar represents 1 mm. Molecular Therapy - Methods & Clinical Development 2014 1, DOI: (10.1038/mtm.2014.54) Copyright © 2014 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 3 Imaging and quantification of in vivo transfected cells in the dermal tissues after pDNA delivery in the presence of surface electroporation (SEP). Guinea pigs were treated ID with 50 µg pGFP and the injection site immediately electroporated with the SEP device. (a) Depiction of migration of reporter gene (GFP) transfected cells from the epidermis to the dermis. Showing GFP+ cells of dendritic cell-like morphology in the epidermis (panels 1 and 2), and the dermis (panels 3 and 4). Images were acquired with a Zeiss LSM 780 laser scanning confocal microscope, and further processed in 3D using Imaris software. Differential interference contrast images compliment the fluorescent images revealing dermal matrix, and the cartoon image identifies the dermal location of the cells in each panel. Reporter gene-positive cells counted in the dermis between 1 and 24 hours after treatment as a percentage (b) or total number (c) of cells in the analyzed section. (d) Single cell suspensions were made form epidermal and dermal sheets, between 1 and 24 hours after treatment. Number of GFP+ cells were determined by FACS. Graphs b–d: mean ± standard error of the mean plotted. ***P < 0.001, **P < 0.01. Molecular Therapy - Methods & Clinical Development 2014 1, DOI: (10.1038/mtm.2014.54) Copyright © 2014 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 4 Identification and interaction with T cells of dendritic cells expressing GFP reporter gene after surface electroporation (SEP) treatment. (a) Guinea pigs harboring immunity to the A/Vietnam/2004 H5HA strain of influenza were treated intradermally with a pDNA cocktail containing 50 µg pGFP and pH5HA in the presence of SEP. Dermis tissue was harvested 24 hours after treatment and stained with anti-CD4 or anti-CD8 PE-conjugated antibodies. Confocal images were modeled using IMARIS software. (b) Six hours after pGFP administration in the presence of SEP, guinea pig skin sections were stained with the Langerhans cells reactive antibody, MsGp2. Images depicts a GFP+ cell staining positive with MsGp2. Molecular Therapy - Methods & Clinical Development 2014 1, DOI: (10.1038/mtm.2014.54) Copyright © 2014 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 5 Expression of reporter gene in cells in draining lymph node. Guinea pigs were treated intradermally with 250 µg pGFP in the presence of surface electroporation on the abdominal flank. Inguinal lymph nodes were excised at between 0 and 72 hours (a) and at 24 hours (b) after treatment. (a) Flow cytometric quantification of number of GFP-positive per draining lymph nodes at the indicated time after treatment (mean + standard error of the mean plotted). **P < 0.01. (b) Fluorescent microscopy of the paracortex region of the inguinal lymph node. GFP (green), CD4 (red), and dapi (blue). Molecular Therapy - Methods & Clinical Development 2014 1, DOI: (10.1038/mtm.2014.54) Copyright © 2014 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 6 Correlation of the migration of dendritic cells out of the dermis to the generation of an immune response. Naive guinea pigs (five per group) were treated intradermally with 100 µg pNP and the site electroporated with surface electroporation. The treatment site was either left intact, or excised 2 or 8 hours after injection. Guinea pigs were bled at day 28 after treatment and anti-nucleoprotein IgG antibody titers detected by enzyme-linked immunosorbent assay (mean + standard error of the mean plotted). Two independent experiments were performed, and one representative data set is shown. Molecular Therapy - Methods & Clinical Development 2014 1, DOI: (10.1038/mtm.2014.54) Copyright © 2014 The American Society of Gene & Cell Therapy Terms and Conditions